Senior Vice President, Corporate Finance, Hutchison China Meditech Limited
Mark Lee is the Senior Vice President of Corporate Finance at Hutchison China Meditech Limited. He joined the company in 2009 and focuses on strategic management, corporate operations and investor relations, and supports its numerous R&D alliances. This includes leading or assisting with the project management of certain clinical programs, coordination of R&D leadership, and R&D financial management.
Prior to joining the company in 2009, Mr. Lee was with Credit Suisse in the United States and Europe, where he was involved in the execution and origination of mergers, acquisitions, public and private financings, and corporate strategy for pharmaceutical, life science and healthcare companies such as AstraZeneca, Bristol-Myers Squibb, Genzyme and Syngenta.
Mr. Lee received his Bachelor degree in Biochemical Engineering with First Class Honors from University College London, where he was awarded a Dean’s Commendation. He also received a Master of Business Administration degree from the Massachusetts Institute of Technology, Sloan School of Management.